YARW · Yarrow Bioscience, Inc. · Executive Compensation
$20.00
+0.43 (+2.20%)
At close · Oct 29
Return incl. dividend (before tax)
Q3 2021 earnings call transcript
Market Cap
$52.15M
Shares
2.67M
Volume · Oct 29
228.61K
Avg daily vol (3M)
108.87K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| David Domzalski | President and Chief Executive Officer | $1,973,607 |
| Iain Stuart | Chief Scientific Officer | $908,430 |
| Mutya Harsch | Chief Legal Officer, General Counsel and Secretary | $891,515 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| David Domzalski | President and Chief Executive Officer | $2,716,350 |
| Iain Stuart | Chief Scientific Officer | $1,164,946 |
| Mutya Harsch | Chief Legal Officer, General Counsel and Secretary | $1,126,090 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David Domzalski | President and Chief Executive Officer | $1,293,464 |
| Mutya Harsch | Chief Legal Officer, General Counsel and Secretary | $654,410 |
| Iain Stuart | Chief Scientific Officer | $653,926 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| David Domzalski | President and Chief Executive Officer | $4,852,925 |
| Mutya Harsch | Chief Legal Officer, General Counsel and Secretary | $1,312,106 |
| Iain Stuart | Chief Scientific Officer | $1,287,359 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| David Domzalski | President and Chief Executive Officer | $2,872,008 |
| Steven Basta | Former President and Chief Executive Officer | $1,614,942 |
| Andrew Saik | Chief Financial Officer and Treasurer | $1,536,537 |
| Mutya Harsch | Chief Legal Officer, General Counsel and Secretary | $907,196 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Steven Basta | Former President and Chief Executive Officer | $1,878,181 |
| Kristine Ball | Former Senior Vice President, Corporate Strategy and Chief Financial Officer | $898,376 |
| Paul Kwon | Former Chief Scientific Officer | $892,888 |
| Andrew Saik | Chief Financial Officer and Treasurer | — |
| David Domzalski | President and Chief Executive Officer | — |
| Mutya Harsch | Chief Legal Officer, General Counsel and Secretary | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Steven Basta | Former President and Chief Executive Officer | $2,605,865 |
| Kristine Ball | Former Senior Vice President, Corporate Strategy and Chief Financial Officer | $1,265,478 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Bill Lundberg | Chair of the Board | Appointed | 2026-07-28 |
| William White | Class II director | Appointed | 2026-07-28 |
| Peter Silverman | Class III director | Appointed | 2026-07-28 |
| Bill Lundberg | Class II director | Appointed | 2026-07-28 |
| Mona Ashiya | Class III director | Appointed | 2026-07-28 |
| Steven Hoerter | Class I director | Appointed | 2026-07-28 |
| Rebecca Frey | Class I director | Appointed | 2026-07-28 |
| Rachael Alford | Chief Operating Officer | Appointed | 2026-07-28 |
| Lori Payton | Chief Development Officer | Appointed | 2026-07-28 |
| Steven Ryder | Chief Medical Officer | Appointed | 2026-07-28 |
| Tyler Zeronda | Chief Financial Officer | Appointed | 2026-07-28 |
| Rebecca Frey | Chief Executive Officer | Appointed | 2026-07-28 |
| Mutya Harsch | Chief Legal Officer and General Counsel | Resigned | 2026-07-28 |
| Iain Stuart | Chief Scientific Officer | Resigned | 2026-07-28 |
| David Domzalski | President and Chief Executive Officer | Resigned | 2026-07-28 |
| Anthony Bruno | member of the Board | Resigned | 2025-08-14 |
| Christine Borowski, Ph.D. | member of the Board | Resigned | 2025-08-14 |
| Patrick LePore | Class III director | Appointed | 2024-12-12 |
| David Domzalski | Class III director | Appointed | 2024-12-12 |
| Dr. Christine Borowski | Class II director | Appointed | 2024-01-03 |
Leadership
- Rebecca Frey CEO, Board Member
- Bill Lundberg Chairman, Board Member
- Andrew Saik CFO
- Ilan Hadar CFO
- Tyler Zeronda CFO
- Rachael Alford COO
- Iain Stuart CTO
- David Domzalski Board Member
- Dr. Christine Borowski Board Member
- Mona Ashiya Board Member
- Mona Ashiya, Ph.D. Board Member
- Patrick G. LePore Board Member
- Peter Silverman Board Member
- Stanley Hirsch Board Member
- Steve Basta Board Member
- Steven Hoerter Board Member
- William White Board Member